Thailand's Public Health Ministry and RxLeaf World Medica will be establishing the International Medical Cannabis Research Center, which will aim to be a knowledge hub for genetic research on medical cannabis, bringing together doctors, researchers, experts from Canada, the Netherlands, and other countries to conduct cannabis products research and development while at the same time exchanging medical cannabis knowledge.
Mr. Anutin Charnvirakul, Deputy Prime Minister of Thailand and Minister of Public Health, said the ministry has been promoting medical cannabis and its safe treatment. The minister also acknowledged the Covid-19 situation has affected the Thai economy, and to alleviate the situation, economic reform and new opportunities are required. "The center is one of the catalysts to support economic recovery. This also conforms to our plans to promote the country as a comprehensive medical hub in Asia, and to encourage the development of the cannabis value chain, including product cultivation, standardization, market expansion, and support for investments in new products," the Thai government stated.
"The medical industry is a key prospect for economic reform due to its global valuation at US$8.3 trillion, while the legalized cannabis market is at approximately US$12.5 billion. Therefore, this is a tremendous opportunity for the country, as we have both the personnel, physical capability, and potential to accept this challenge."
For more information:
Amara Asia
www.amaraasia.com
